ATE512950T1 - Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem amino - Google Patents
Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem aminoInfo
- Publication number
- ATE512950T1 ATE512950T1 AT05710622T AT05710622T ATE512950T1 AT E512950 T1 ATE512950 T1 AT E512950T1 AT 05710622 T AT05710622 T AT 05710622T AT 05710622 T AT05710622 T AT 05710622T AT E512950 T1 ATE512950 T1 AT E512950T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- cyclic compound
- substituted amino
- group
- new cyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004039862 | 2004-02-17 | ||
JP2004294347 | 2004-09-06 | ||
PCT/JP2005/002971 WO2005085201A1 (ja) | 2004-02-17 | 2005-02-17 | 置換又は無置換アミノ基を導入した4-ピリジルアルキルチオ基を有する新規環式化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE512950T1 true ATE512950T1 (de) | 2011-07-15 |
Family
ID=34921640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05710622T ATE512950T1 (de) | 2004-02-17 | 2005-02-17 | Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem amino |
Country Status (12)
Country | Link |
---|---|
US (1) | US7544703B2 (de) |
EP (1) | EP1717229B1 (de) |
KR (1) | KR101179840B1 (de) |
AT (1) | ATE512950T1 (de) |
AU (1) | AU2005219689B2 (de) |
BR (1) | BRPI0507757A (de) |
CA (1) | CA2555712C (de) |
DK (1) | DK1717229T3 (de) |
NZ (1) | NZ548949A (de) |
PL (1) | PL1717229T3 (de) |
PT (1) | PT1717229E (de) |
WO (1) | WO2005085201A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI422583B (zh) * | 2003-03-07 | 2014-01-11 | 參天製藥股份有限公司 | 具有以4-吡啶烷硫基為取代基之新穎化合物 |
ES2548729T3 (es) * | 2005-03-31 | 2015-10-20 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que tiene grupo pirimidinilalquiltio |
EP2128156A4 (de) | 2007-01-29 | 2011-05-18 | Santen Pharmaceutical Co Ltd | Neue oxadiazolderivate und thiadiazolderivate mit die neovaskularisierung hemmender wirkung |
EA019689B1 (ru) | 2009-07-17 | 2014-05-30 | Сантен Фармасьютикал Ко., Лтд. | Бензолсульфонат 2-[[[2-[(гидроксиацетил)амино]-4-пиридинил]метил]тио]-n-[4-(трифторметокси)фенил]-3-пиридинкарбоксамида, его кристаллы, его полиморфы и способы их получения |
CN105555271A (zh) * | 2013-09-20 | 2016-05-04 | 参天制药株式会社 | 含有聚乙二醇的组合物 |
EP3272360B1 (de) * | 2015-03-17 | 2022-11-23 | Santen Pharmaceutical Co., Ltd. | Pharmazeutische zusammensetzung mit einem polypeptid |
KR20230104762A (ko) * | 2015-03-18 | 2023-07-10 | 산텐 세이야꾸 가부시키가이샤 | 서방성 의약 조성물 |
WO2016178900A1 (en) * | 2015-05-01 | 2016-11-10 | Odin Biotech | Ocular implant for delivery of pyridinecarboxamide derivative |
AR105955A1 (es) * | 2015-09-08 | 2017-11-29 | Santen Pharmaceutical Co Ltd | Método para producir una piridinacarboxamida |
PL237497B1 (pl) * | 2018-09-17 | 2021-04-19 | Univ Medyczny Im Piastow Slaskich We Wroclawiu | Hydrazyd kwasu N’-[(antracen-9-ylo)metyleno]-2-[4,6-dimetylo- 2-sulfanylopirydyn-3-ylo-karboksamido]octowego, sposób jego otrzymywania i zastosowanie |
KR102146521B1 (ko) | 2020-01-06 | 2020-08-20 | (주)포스젯한도 | 아연도금설비의 용융아연 도금욕조용 메탈베어링 장치 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02129173A (ja) | 1988-11-10 | 1990-05-17 | Ishihara Sangyo Kaisha Ltd | トリアゾール系化合物、それらの製造方法及びそれらを含有する有害生物防除剤 |
DE3929673A1 (de) | 1989-09-07 | 1991-03-14 | Bayer Ag | Substituierte carbamoyltriazole |
JP2501051B2 (ja) | 1991-09-30 | 1996-05-29 | バンドー化学株式会社 | 搬送用ベルトの製造方法 |
KR19990082463A (ko) | 1996-02-13 | 1999-11-25 | 돈 리사 로얄 | 혈관 내피 성장 인자 억제제로서의 퀴나졸린유도체 |
CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
CA2289102A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
US6329372B1 (en) * | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
NZ533107A (en) | 2001-11-08 | 2007-04-27 | Upjohn Co | N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
US20050113450A1 (en) | 2002-08-23 | 2005-05-26 | Atli Thorarensen | Antibacterial agents |
US20040110802A1 (en) | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
TWI422583B (zh) | 2003-03-07 | 2014-01-11 | 參天製藥股份有限公司 | 具有以4-吡啶烷硫基為取代基之新穎化合物 |
-
2005
- 2005-02-17 EP EP05710622A patent/EP1717229B1/de not_active Not-in-force
- 2005-02-17 CA CA2555712A patent/CA2555712C/en not_active Expired - Fee Related
- 2005-02-17 BR BRPI0507757-5A patent/BRPI0507757A/pt not_active Application Discontinuation
- 2005-02-17 DK DK05710622.1T patent/DK1717229T3/da active
- 2005-02-17 NZ NZ548949A patent/NZ548949A/en not_active IP Right Cessation
- 2005-02-17 KR KR1020067019034A patent/KR101179840B1/ko active IP Right Grant
- 2005-02-17 AU AU2005219689A patent/AU2005219689B2/en not_active Ceased
- 2005-02-17 US US10/587,410 patent/US7544703B2/en not_active Expired - Fee Related
- 2005-02-17 AT AT05710622T patent/ATE512950T1/de not_active IP Right Cessation
- 2005-02-17 PT PT05710622T patent/PT1717229E/pt unknown
- 2005-02-17 WO PCT/JP2005/002971 patent/WO2005085201A1/ja active Application Filing
- 2005-02-17 PL PL05710622T patent/PL1717229T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
KR101179840B1 (ko) | 2012-09-04 |
AU2005219689A1 (en) | 2005-09-15 |
CA2555712A1 (en) | 2005-09-15 |
AU2005219689B2 (en) | 2011-06-09 |
PL1717229T3 (pl) | 2011-11-30 |
US20070149574A1 (en) | 2007-06-28 |
DK1717229T3 (da) | 2011-09-19 |
BRPI0507757A (pt) | 2007-07-10 |
EP1717229B1 (de) | 2011-06-15 |
EP1717229A1 (de) | 2006-11-02 |
US7544703B2 (en) | 2009-06-09 |
EP1717229A4 (de) | 2009-07-15 |
NZ548949A (en) | 2009-09-25 |
KR20060135818A (ko) | 2006-12-29 |
CA2555712C (en) | 2013-04-23 |
PT1717229E (pt) | 2011-09-12 |
WO2005085201A1 (ja) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE512950T1 (de) | Neue cyclische verbindung mit 4- pyridylalkylthiogruppe mit darin eingeführtem (un)substituiertem amino | |
CY1117299T1 (el) | Ανθρανιλαμιδια, μεθοδος για την παρασκευη αυτων και παραγοντες ελεγχου επιβλαβων εντομων που τα περιεχουν | |
EA200602170A1 (ru) | Производные пиперидина, композиции на их основе, способы их применения | |
ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
ATE336991T1 (de) | Bis(thio-hydrazid amid) verbindungen zur behandlung von mehrfach resistenten krebs | |
AR035763A1 (es) | Compuestos derivados de diamidas heterociclicas, metodo para controlar una plaga de invertebrados y composicion que lo comprende | |
TW200510441A (en) | Novel compounds | |
MXPA04001286A (es) | Arilamidas orto-heterociclicas sustituidas para controlar plagas de invertebrados. | |
EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
CY1109510T1 (el) | Επιλεγμενοι ανταγωνιστες toy cgrp, μεθοδος για την παραγωγη τους και για τη χρηση τους ως φαρμακων | |
DE60224400D1 (de) | Hepatitis c virus polymerase inhibitoren mit heterobicylische struktur | |
CO5590957A2 (es) | Amino-1,3,5-triazinas sustituidas en n con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas y su uso como herbicidas y reguladores del crecimiento de las plantas | |
HRP20080541T3 (en) | Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases | |
TW200732309A (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
DE60128542D1 (de) | Stickstoffhaltige cyclische verbindungen und sie enthaltende pharmazeutische zubereitungen | |
BR9508900A (pt) | Derivado heterocíclico e medicamento | |
AR117200A1 (es) | Derivados de tiazol microbiocidas | |
EA201100009A1 (ru) | Соединения 1,2-бензизотиазола, полезные для борьбы с животными-вредителями | |
MA28285A1 (fr) | Dérivés de spiropipéridine pour lutter contre les organismes nuisibles | |
EP1640366A4 (de) | Heterocyclsches methylsulfonderivativ | |
AR037940A1 (es) | Compuestos antivirales de piridoquinoxalina | |
DE60137437D1 (de) | Promotoren zur proliferation und differenzierung von stammzellen und/oder vorstufen von neuronenzellen | |
AR040123A1 (es) | Compuestos tiofeno, antihelminticos e insecticidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |